Opportunity

Mohawk Medbuy Corporation Bonfire #CW17475

Solicitation for Neurovascular and Embolic Protection Devices (2027)

Posted

May 21, 2026

Respond By

July 03, 2026

Identifier

CW17475

NAICS

423450, 423460

Mohawk Medbuy Corporation is seeking proposals for the supply of a comprehensive range of neurovascular and embolic protection devices for use in Canadian healthcare facilities in 2027. - Government Buyer: - Mohawk Medbuy Corporation (acting as a group purchasing organization for Canadian healthcare institutions) - Products/Services Requested: - Neurovascular and embolic protection devices, including: - Balloon occlusion catheters - Neurovascular stent retrievers - Microcatheters - Neurovascular stents - Embolic protection devices - Embolization liquids and particles - Neuro embolization coils and accessories - Neurovascular access catheters - Aspiration catheters - Guide catheters - Neurovascular flow diverters - Neurovascular guidewires - Neurovascular intrasaccular devices - Notable Requirements: - Proponents must provide detailed product and pricing schedules - Submission of confirmation forms, declarations, and supporting schedules is required - Products must be latex-free or proponents must explain how they will service latex-free hospitals - Business, clinical, and regional criteria must be addressed - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Quantities and part numbers: - Not specified in the notice; detailed information to be provided by proponents

Description

This solicitation is a Request for Proposal (RFP) for MILR Neuro Products for the year 2027. The project involves procurement of various neurovascular and embolic protection devices, including balloon occlusion catheters, neurovascular stent retrievers, microcatheters, and related products. Proponents are required to submit detailed schedules and forms including product and pricing schedules, proponent confirmation, and declarations. The solicitation includes multiple supporting documents and requires completion of business, clinical, and regional criteria by all proponents.

View original listing